Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

cetrorelix 2Vitamin D 2Metformin 2Chorionic Gonadotropin 2mazdutide 1drospirenone and ethinyl estradiol combination 1Triptorelin Pamoate 1Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1Sitagliptin Phosphate 1Secretome 1Rehydration Solutions 1Menotropins 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Gonadotropins 1Glucagon-Like Peptide-1 Receptor 1Folic Acid 1Diet 1Clomiphene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Polycystic Ovary Syndrome × mazdutide × Clear all
NCT06519656 2024-10-24

Efficacy of Mazdutide for Treating PCOS

Shanghai Zhongshan Hospital

Phase 1/2 Recruiting
50 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡